Why Moderna Stock Is Slipping Today
Shares of Moderna (NASDAQ: MRNA) were slipping 2.7% lower as of 11:27 a.m. ET on Tuesday after falling as much as 4.8% earlier in the morning. This decline came despite Morgan Stanley analyst Matthew Harrison stating today that Moderna's shares could jump between 10% and 20% with positive early data for its experimental flu vaccine.
So why did the vaccine stock fall instead of jump? It's probably because more investors are paying attention to CNBC's Jim Cramer instead of Morgan Stanley's Harrison. Cramer stated on the CNBC show Mad Money on Monday: "Moderna is very hard for me. It's just a hold here. Got to go back to where it was."
Image source: Getty Images.
Source Fool.com
